查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726347

全球細胞再程式化市場：市場規模、佔有率、趨勢分析（按技術、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Cell Reprogramming Market Size, Share & Trends Analysis Report By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

細胞再程式化市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球細胞再程式化市場規模預計到2030年將達到6.642億美元，2025年至2030年的複合年成長率為8.55%。

預計癌症研究中擴大採用細胞再程式化以及對細胞再程式化的日益關注等因素將推動市場成長。此外，重點關注合作研究和主要企業之間的夥伴關係預計將推動市場成長。 mRNA再程式化技術的進步將能夠從體細胞組織快速、安全、有效率地產生臨床級人類 iPS 細胞。此外，由於mRNA的尺寸較小，轉染過程比其他重編程載體更容易。當利用難以再程式化的樣本時，mRNA再程式化可以將再程式化效率提高1%。

此外，對 mRNA 重編程技術的需求日益增加，因為這種方法可以更快、更安全地從體細胞組織中產生高品質的人類 iPS 細胞。此外，它還能夠將人類幹細胞重新編程為幼稚狀態，重現最早的發育階段。例如，2022 年 3 月，巴布拉漢研究所的研究人員發現了加速這個初始化過程的關鍵因素。這項新發現使研究人員能夠簡化和加速幼稚多功能細胞的生成。此外，在政府和公共資金的大力推動下，細胞重編程正在蓬勃發展。這種支持是對其為醫療保健行業帶來的各種好處的回應，特別是在潛在的醫療應用方面。

此外，細胞再程式化最近已被研究人員從實驗室重新定位到臨床。這種變化在各種臨床和學術研究領域都很明顯，包括與再生醫學、疾病建模、藥物毒性和藥物發現相關的領域。細胞再程式化的臨床效用在再生醫學中特別明顯。越來越多的旨在透過細胞再程式化開發創新產品的策略性舉措正在推動研究和學術領域的成長。例如，加州再生醫學研究所正在資助研究小組，以推動細胞再程式化應用於臨床治療。

細胞再程式化市場報告重點

  • mRNA再程式化技術領域預計將在 2024 年佔據最大的收益佔有率，達到 32.63%，因為它易於使用、速度快、安全高效，同時可以從體細胞組織中生成高品質的人類 iPS 細胞。
  • 2024 年，研究應用領域佔據市場主導地位，佔有率為 67.30%。成長的主要驅動力之一是利用幹細胞進行細胞再程式化領域的持續研究。
  • 研究和學術機構最終用途部門在 2024 年的收入佔有率為 67.30%。這一成長是由細胞再程式化在各種臨床和學術研究計劃中的應用所推動的，包括再生療法、疾病建模和藥物毒性/藥物發現研究。
  • 由於北美地區擁有領先公司，因此在 2024 年佔據了全球行業的主導地位，收入佔有率為 39.69%。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 按技術進行的業務分析

  • 技術儀表板
  • 細胞再程式化市場：依技術進行差異分析
  • 基於仙台病毒的再程式化
    • 仙台病毒重再程式化市場（2018-2030）
  • mRNA再程式化
    • mRNA再程式化市場（2018-2030）
  • 遊離重再程式化
    • 表觀遺傳學再程式化市場（2018-2030）
  • 其他
    • 其他再程式化市場（2018-2030）

第 5 章 按應用程式進行的業務分析

  • 特定於應用程式的儀表板
  • 細胞再程式化市場：依應用進行的變化分析
  • 研究
    • 研究市場（2018-2030）
  • 治療
    • 治療市場（2018-2030）

第6章 以最終用途分類的業務分析

  • 按最終用途分類的儀表板
  • 細胞再程式化市場：依最終用途的變化分析
  • 研究和學術機構
    • 研究與學術機構市場（2018-2030）
  • 生物技術和製藥公司
    • 生物技術和製藥市場（2018-2030）

第7章區域業務分析

  • 區域儀表板
  • 各地區細胞再程式化市場佔有率（2018-2030）
  • 北美洲
    • 北美細胞再程式化市場（2018-2030）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲細胞再程式化市場（2018-2030）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太細胞再程式化市場（2018-2030）
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲細胞再程式化市場（2018-2030）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲細胞再程式化市場（2018-2030）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Allele Biotechnology and Pharmaceuticals Inc.
    • ALSTEM
    • STEMCELL Technologies
    • Merck KGaA
    • Bio-Techne
    • REPROCELL Inc.
    • Lonza
    • FUJIFILM Corporation（Fujifilm Cellular Dynamics）
    • Mogrify Limited
Product Code: GVR-4-68039-966-2

Cell Reprogramming Market Growth & Trends:

The global cell reprogramming market size is estimated to reach USD 664.2 million by 2030, registering a CAGR of 8.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.

Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.

Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.

Cell Reprogramming Market Report Highlights:

  • The mRNA reprogramming technology segment held the largest revenue share of 32.63% in 2024, due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue.
  • The research application segment led the market with a share of 67.30% in 2024. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells.
  • The research & academic institute end-use segment held a revenue share of 67.30% in 2024. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies.
  • North America dominated the global industry in 2024, with a revenue share of 39.69%, owing to the presence of key players in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Platform & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Platform & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing focus on cell reprogramming
      • 3.2.1.2. Increasing adoption of cell reprogramming in cancer research
      • 3.2.1.3. Emphasis on collaborations and partnerships among key players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with iPSCs
      • 3.2.2.2. Limited awareness regarding treatment option
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Cell Reprogramming Market: Technology Movement Analysis
  • 4.3. Sendai Virus-based Reprogramming
    • 4.3.1. Sendai Virus-based Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.4. mRNA Reprogramming
    • 4.4.1. mRNA Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.5. Episomal Reprogramming
    • 4.5.1. Episomal Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Cell Reprogramming Market: Application Movement Analysis
  • 5.3. Research
    • 5.3.1. Research Market, 2018 - 2030 (USD Million)
  • 5.4. Therapeutics
    • 5.4.1. Therapeutics Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Cell Reprogramming Market: End-use Movement Analysis
  • 6.3. Research & Academic Institutes
    • 6.3.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Biotechnology & Pharmaceutical Companies
    • 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Cell Reprogramming Market Share by Region, 2018- 2030
  • 7.3. North America
    • 7.3.1. North America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. U.S. Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Canada Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Mexico Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. UK Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Germany Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. France Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Italy Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Spain Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Denmark Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Sweden Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Norway Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Japan Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. China Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. India Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Australia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Thailand Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. South Korea Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Brazil Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Argentina Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. South Africa Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Saudi Arabia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. UAE Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Kuwait Cell Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Allele Biotechnology and Pharmaceuticals Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. ALSTEM
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. STEMCELL Technologies
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Bio-Techne
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. REPROCELL Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Lonza
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Mogrify Limited
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Cell Reprogramming Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 Mexico Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 UK Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 UK Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 UK Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 Germany Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 Germany Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 France Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 France Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 France Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Spain Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Italy Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Italy Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Italy Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Denmark Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Norway Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Norway Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 46 Sweden Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Sweden Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 China Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 China Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 Japan Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 Japan Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 Japan Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 India Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 India Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 India Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 South Korea Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Australia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Australia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Australia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Thailand Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Latin America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Brazil Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 82 MEA Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 UAE Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell Reprogramming market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global cell reprogramming market: Technology outlook and key takeaways
  • Fig. 15 Global cell reprogramming market: Technology movement analysis
  • Fig. 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018 - 2030 (USD Million)
  • Fig. 17 Global cell reprogramming market, for mRNA reprogramming, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell reprogramming market, for episomal reprogramming, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell reprogramming market, for others, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell reprogramming market: Application outlook and key takeaways
  • Fig. 21 Global cell reprogramming market: Application movement analysis
  • Fig. 22 Global cell reprogramming market, for research, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell reprogramming market, for therapeutic, 2018 - 2030 (USD Million)
  • Fig. 24 Global cell reprogramming market: End-use outlook and key takeaways
  • Fig. 25 Global cell reprogramming market: End-use movement analysis
  • Fig. 26 Global cell reprogramming market, for research & academic institutes, 2018 - 2030 (USD Million)
  • Fig. 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 North America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Key country dynamics
  • Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Key country dynamics
  • Fig. 34 Canada cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Key country dynamics
  • Fig. 36 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Key country dynamics
  • Fig. 39 Germany cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Key country dynamics
  • Fig. 41 UK cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 42 France Key country dynamics
  • Fig. 43 France cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Key country dynamics
  • Fig. 45 Italy cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Key country dynamics
  • Fig. 47 Spain cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Key country dynamics
  • Fig. 49 Denmark cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Key country dynamics
  • Fig. 51 Sweden cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Key country dynamics
  • Fig. 53 Norway cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan Key country dynamics
  • Fig. 56 Japan cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 57 China Key country dynamics
  • Fig. 58 China cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 59 India Key country dynamics
  • Fig. 60 India cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Key country dynamics
  • Fig. 62 Australia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Key country dynamics
  • Fig. 64 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand Key country dynamics
  • Fig. 66 Thailand cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil Key country dynamics
  • Fig. 69 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Key country dynamics
  • Fig. 71 Argentina cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa Key country dynamics
  • Fig. 74 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia Key country dynamics
  • Fig. 76 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE Key country dynamics
  • Fig. 78 UAE cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Key country dynamics
  • Fig. 80 Kuwait cell reprogramming market, 2018 - 2030 (USD Million)